Skip to main navigation
Skip to search
Skip to main content
Oregon Health & Science University Home
Help & FAQ
Home
Profiles
Research units
Core Facilities
Publications
Search by expertise, name or affiliation
Drug approval highlights for 2003
Gary Laustsen, Lynn Wimett
School of Nursing
Research output
:
Contribution to journal
›
Article
›
peer-review
5
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Drug approval highlights for 2003'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Drug Approval
100%
FluMist
49%
efalizumab
42%
alfuzosin
42%
Vardenafil Dihydrochloride
40%
Valacyclovir
38%
oxybutynin
38%
Omalizumab
37%
Daptomycin
35%
Carvedilol
35%
Rosuvastatin Calcium
35%
Herpes Genitalis
34%
Pharmaceutical Preparations
32%
Heterosexuality
29%
Prostatic Hyperplasia
28%
Urinary Incontinence
28%
Erectile Dysfunction
27%
Hypercholesterolemia
25%
Psoriasis
25%
Human Influenza
23%
Health Personnel
22%
Primary Health Care
20%
Asthma
20%
Heart Failure
18%
Hormones
18%
Equipment and Supplies
15%
Skin
14%
Infections
12%
Therapeutics
4%